Directorate Change

RNS Number : 3220V
Eco Animal Health Group PLC
09 August 2022
 

9 August 2022

ECO Animal Health Group plc

(''ECO", the "Company" or the "ECO Group") (AIM: EAH)

Directorate Change


ECO Animal Health plc announces today that Tony Rawlinson, Non-Executive Director, has resigned from the Board to pursue other business opportunities, with immediate effect.

Andrew Jones the Chairman of ECO Animal Health commented:

"Tony has been a Non-Executive Director at ECO Animal Health plc for nearly eight years and has been involved in the development and implementation of important changes in corporate governance and remuneration policy.  The Board sincerely thanks him for his much-valued contribution and wish him well for the future."

 

 

For further information please contact:

ECO Animal Health Group plc

David Hallas (CEO)

Christopher Wilks (CFO)

 

020 8447 8899

 

 

IFC Advisory

Graham Herring

Zach Cohen

 

 

020 3934 6630

 

 

Singer Capital Markets (Nominated Adviser & Joint Broker)

Mark Taylor

George Tzimas

 

020 7496 3000

 

Investec (Joint Broker)

Gary Clarence

Brough Ransom

Carlo Spingardi

 

Peel Hunt LLP (Joint Broker)

Dr Christopher Golden

James Steel

 

020 7597 5970

 

 

 

 

020 7418 8900

 

Equity Development

Hannah Crowe

Matt Evans

020 7065 2692

 

 About ECO Animal Health

ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUAPRUPPGMR
UK 100

Latest directors dealings